The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of the mitochondrial metabolism inhibitor cpi-613 in combination with high dose Ara-C (HDAC) and mitoxantrone in high risk relapsed or refractory acute myeloid leukemia (AML).
 
Timothy S. Pardee
Honoraria - Cornerstone Pharmaceuticals
Consulting or Advisory Role - Johnson & Johnson; Sunesis Pharmaceuticals
Speakers' Bureau - Celgene; Novartis
Research Funding - Cornerstone Pharmaceuticals (Inst)
 
Kristin Stadelman
No Relationships to Disclose
 
Scott Isom
No Relationships to Disclose
 
Leslie R. Ellis
No Relationships to Disclose
 
Dmitriy Berenzon
Consulting or Advisory Role - Incyte
 
David Duane Hurd
Stock and Other Ownership Interests - Bristol-Myers Squibb; Johnson & Johnson; Medtronic; Merck; Pfizer; Procter & Gamble; Targacept
 
Dianna S. Howard
No Relationships to Disclose
 
Robin Harrelson
No Relationships to Disclose
 
Megan Manuel
Speakers' Bureau - Novartis
 
Sarah Dralle
No Relationships to Disclose
 
Susan Lyerly
No Relationships to Disclose
 
Bayard L. Powell
Consulting or Advisory Role - Cornerstone Pharmaceuticals
Speakers' Bureau - Celgene